|
Demographic
|
n = 370
|
|---|
|
Gender (% Male)
|
65
|
|
Age (years)
|
70.2 (8.8)
|
|
Smoking status (Current %)
|
30.0
|
|
Pack years
|
46.0 [10.0–220.0]
|
|
BMI (kg/m2)
|
26.2 [15.6–49.2]
|
|
Exacerbations (1 year prior)
|
1.0 [0.0–15.0]
|
|
Inhaled steroid use %
|
78.8
|
|
Oral steroid use %
|
3.8
|
|
LABA use %
|
70.7
|
|
LAMA use %
|
75.0
|
|
Azithromycin use %
|
3.5
|
|
Post BD FEV1 (L)
|
1.4 (0.6)
|
|
Post BD FEV1 %
|
57.0 [20.0–117.0]
|
|
Post BD Ratio
|
0.5 [0.2–0.8]
|
|
GOLD A n (%)
|
34 (9.2)
|
|
GOLD B n (%)
|
107 (28.9)
|
|
GOLD C n (%)
|
12 (3.2)
|
|
GOLD D n (%)
|
217 (58.7)
|
- Summaries are presented as percentages, Mean (SD) or Median [Range] as appropriate
- Definitions of abbreviations; BMI body mass index, LABA long acting beta agonist, LAMA long acting muscarinic antagonist, Post BD post bronchodilator, FEV
1
forced expired volume in first second
